Jubilant Ingrevia Limited
All news and filings related to Jubilant Ingrevia Limited.
View all news & filings- Medium impact
Jubilant Ingrevia: Sr. VP Supply Chain Resigns Effective Nov 5, 2026
Mr. Birajeev Singh, Sr. Vice President - Supply Chain at Jubilant Ingrevia Limited, has resigned. His resignation is effective November 5, 2026. The company announced this change on October 1, 2026, citing a better opportunity as the reason for his departure.
Read the summary - Medium impact
Jubilant Ingrevia to Increase ESOP Pool by 10 Lakhs to 30 Lakhs Options
Jubilant Ingrevia's Board approved increasing its ESOP Pool from 20 lakh to 30 lakh stock options, subject to shareholder approval. This move aims to support long-term growth and talent retention. The increase represents 1.88% of the paid-up capital as of September 30, 2026.
Read the summary - Medium impact
Jubilant Ingrevia to acquire 40% stake in Zettaone via new subsidiary
Jubilant Ingrevia will acquire a 40% stake in Zettaone Technologies via a new wholly-owned subsidiary, Jubilant Advanced Electronics Limited. The investment, up to ₹10 crore, aims to strengthen the company's presence in the EDMS sector and electronics/semiconductor ecosystem.
Read the summary - Low impact
Jubilant Ingrevia Closes Trading Window from Oct 1, 2026, for Q2 FY27 Results
Jubilant Ingrevia Limited will close its trading window from October 01, 2026. The window will remain closed until 48 hours after the announcement of financial results for the quarter and half-year ending September 30, 2026. Designated persons are restricted from trading during this period.
Read the summary - Low impact
Jubilant Ingrevia sets December 22, 2026 as record date for ₹100 Crore Commercial Paper maturity
Jubilant Ingrevia Limited has set December 22, 2026, as the record date for the maturity of its ₹100 crore Commercial Paper issuance. The CPs, issued on September 24, 2026, will mature on December 23, 2026.
Read the summary - Low impact
Jubilant Ingrevia Issues ₹100 Cr Commercial Papers Maturing in 90 Days
Jubilant Ingrevia Limited issued ₹100 Crores in Commercial Papers on September 24, 2026. The CPs have a 90-day tenure, maturing on December 23, 2026, with an interest rate of 6.30% per annum. The Finance Committee previously approved issuances up to ₹600 crore.
Read the summary - Medium impact
Jubilant Ingrevia's 7th AGM: All Resolutions Passed, Dividend of ₹2.50 Approved
Jubilant Ingrevia Limited's 7th AGM on August 26, 2026, saw all resolutions passed. Shareholders approved the audited financial statements for FY26 and a final dividend of ₹2.50 per equity share. Directors Mr. Shyam S. Bhartia and Mr. Priyavrat Bhartia were re-appointed. Cost Auditor remuneration was also ratified.
Read the summary - Medium impact
Jubilant Ingrevia Ltd Holds 7th AGM: All Resolutions Passed, Final Dividend Approved
Jubilant Ingrevia Limited's 7th AGM on August 26, 2026, passed all resolutions. Key approvals include adopting FY26 financial statements and declaring a final dividend of ₹2.50 per share. Directors Shyam S. Bhartia and Priyavrat Bhartia were re-appointed.
Read the summary - High impact
Jubilant Ingrevia to acquire 40% stake in Zettaone for ₹189.2 Cr
Jubilant Ingrevia will acquire a 40% stake in Zettaone Technologies for ₹189.2 crore. This strategic move aims to bolster its presence in the EDMS sector. The acquisition will occur in two tranches, with completion expected by November 2026 and September 2027.
Read the summary - Medium impact
Jubilant Ingrevia to acquire 40% stake in Zettaone for ₹189.2 Cr
Jubilant Ingrevia Limited will acquire a 40% stake in Zettaone Technologies for ₹189.2 crore. The acquisition will be completed in two tranches by November 2026 and September 2027. Zettaone is an electronics design and manufacturing platform.
Read the summary - Low impact
Jubilant Ingrevia to participate in Equirus Annual India Conference 2026
Jubilant Ingrevia Limited will participate in the Equirus Annual India Conference 2026 in Mumbai on August 13-14, 2026. Management will hold one-on-one meetings with investors and analysts. Discussions will be based on publicly available information.
Read the summary - Low impact
Jubilant Ingrevia to Participate in Nuvama India Conference 2026 in Singapore
Jubilant Ingrevia Limited will attend the Nuvama India Conference 2026 in Singapore on August 11-12, 2026. Management will hold one-on-one meetings with investors and analysts.
Read the summary - Low impact
Jubilant Ingrevia Announces 7th AGM, E-Voting, Record Date, and Final Dividend
Jubilant Ingrevia Limited has announced its 7th AGM, e-voting details, record date, and final dividend. The Notice of AGM and Annual Report for FY26 were disseminated via email on August 1, 2026. Newspaper advertisements were published on August 2, 2026.
Read the summary - Low impact
Jubilant Ingrevia schedules 7th AGM for Aug 26, 2026; Annual Report FY26 released
Jubilant Ingrevia Limited will hold its 7th AGM on August 26, 2026, via VC/OAVM. The Annual Report for FY 2025-26 and AGM Notice are available. E-voting runs from August 23-25, 2026. The record date for final dividend is July 24, 2026.
Read the summary - Medium impact
Jubilant Ingrevia: ₹2.50 Final Dividend for FY26, Record Date July 24
Jubilant Ingrevia recommended a final dividend of ₹2.50 per equity share for FY26. The record date for payment is July 24, 2026. Shareholders need to submit TDS-related declarations by August 14, 2026, to avail nil or lower tax deduction rates.
Read the summary - Low impact
Jubilant Ingrevia Submits FY26 Business Responsibility and Sustainability Report
Jubilant Ingrevia Limited has submitted its Business Responsibility and Sustainability Report for FY 2025-26. The report details business activities, export contribution, and workforce information. It also outlines strategies and targets for environmental and social matters, with achievements in reducing GHG emissions and water consumption. The company aims for increased female workforce participation by FY27.
Read the summary - Medium impact
Jubilant Ingrevia schedules 7th AGM for August 26, 2026, proposes ₹2.50 dividend
Jubilant Ingrevia Limited will hold its 7th AGM on August 26, 2026, via VC/OAVM. The company proposes a final dividend of ₹2.50 per share for FY26 and will present audited financial statements. Directors Shyam S. Bhartia and Priyavrat Bhartia are up for re-appointment. Cost auditor remuneration of ₹4.75 lakh is also to be ratified.
Read the summary - Low impact
Jubilant Ingrevia Ltd. Announces 7th AGM on August 26, 2026
Jubilant Ingrevia Limited's 7th Annual General Meeting is scheduled for August 26, 2026. The company will distribute the AGM notice and annual report electronically to shareholders. Newspaper advertisements regarding the AGM were published on July 30, 2026.
Read the summary - High impact
Jubilant Ingrevia Q1 FY27 Earnings Call Transcript Released
Jubilant Ingrevia reported Q1 FY27 revenue of ₹1,300 crore, up 25% YoY, and EBITDA of ₹209 crore, up 36% YoY. PAT was ₹106 crore, a 41% YoY increase. The company maintains its FY27 EBITDA guidance of ₹750-800 crore and expects sequential growth.
Read the summary - Low impact
Jubilant Ingrevia Publishes Q1 FY27 Financial Results
Jubilant Ingrevia Limited published its unaudited standalone and consolidated financial results for the quarter ended June 30, 2026. The results were approved by the board on July 22, 2026, and published in newspapers on July 24, 2026. Full results are available on the company website.
Read the summary - Low impact
Jubilant Ingrevia: Audio Recording of Q1 FY27 Investor Call Available
Jubilant Ingrevia Limited has uploaded the audio recording of its investor conference call for the quarter ending June 30, 2026. The call took place on July 23, 2026. The recording is accessible on the company's website.
Read the summary - High impact
Jubilant Ingrevia Q1 FY27 Revenue Up 25% to ₹1,300 Cr, EBITDA Rises 36%
Jubilant Ingrevia reported Q1 FY27 results with revenue up 25% YoY to ₹1,300 Cr and EBITDA up 36% YoY to ₹209 Cr. PAT grew 41% YoY to ₹106 Cr. Specialty Chemicals revenue increased 11% YoY, Nutrition grew 36% YoY, and Chemical Intermediates revenue surged 38% YoY.
Read the summary - High impact
Jubilant Ingrevia Q1 FY27 Revenue Jumps 25% to ₹1,300 Cr, EBITDA Up 36%
Jubilant Ingrevia reported Q1 FY27 revenue of ₹1,300 crore (up 25% YoY) and EBITDA of ₹209 crore (up 36% YoY). PAT grew 41% YoY to ₹106 crore, and EPS rose to ₹6.7. Specialty Chemicals revenue was ₹533 crore, Nutrition & Health Solutions ₹243 crore, and Chemical Intermediates ₹524 crore. The company expects sequential revenue and EBITDA improvement.
Read the summary - Medium impact
Jubilant Ingrevia Q1FY27 Results: Consolidated Revenue ₹13,003 Crore, Profit ₹105.82 Crore
Jubilant Ingrevia reported Q1FY27 results with consolidated revenue at ₹13,003 crore and profit after tax of ₹10,582 crore. Standalone profit after tax was ₹12,622 crore. The company maintained strong debt service coverage ratios and operating margins.
Read the summary - Medium impact
Jubilant Ingrevia Q1 FY27 Results: Revenue ₹13,003 Crore, Net Profit ₹105.82 Crore
Jubilant Ingrevia reported Q1 FY27 consolidated revenue from operations at ₹13,003 crore and net profit at ₹105.82 crore. Standalone net profit was ₹126.22 crore. The company's Board of Directors approved these unaudited financial results on July 22, 2026.
Read the summary - Low impact
Jubilant Ingrevia Grants 42,298 Stock Options Under ESOP 2021
Jubilant Ingrevia Limited granted 42,298 stock options on July 22, 2026, under its ESOP 2021. This includes 34,808 RSUs and 7,490 PSUs. RSUs vest in 3 years, PSUs in 1 year. Exercise price is Re. 1 per share.
Read the summary - Low impact
Jubilant Ingrevia to Host Investor Conference Call on July 23, 2026
Jubilant Ingrevia Limited will hold an investor conference call on July 23, 2026, at 5:00 PM IST to discuss financial results for the quarter ended June 30, 2026. Pre-registration is available for participants.
Read the summary - Low impact
Jubilant Ingrevia Files SEBI Compliance Certificate for Q1 FY27
Jubilant Ingrevia Limited filed a certificate under SEBI regulations for the quarter ended June 30, 2026. The certificate confirms the listing and cancellation of share certificates, with depository names substituted as registered owners.
Read the summary - Low impact
Jubilant Ingrevia Closes Trading Window from July 1 for Q1 FY27 Results
Jubilant Ingrevia Limited will close its trading window from July 1, 2026, until 48 hours after the announcement of Q1 FY27 financial results. Designated persons are restricted from trading during this period. The board meeting date for results approval will be announced later.
Read the summary - Low impact
Jubilant Ingrevia Schedules Investor Meet on June 30, 2026
Jubilant Ingrevia Limited will conduct an in-person group meeting with Analysts/Institutional Investors on June 30, 2026, in Bharuch. Discussions will be based on publicly available information.
Read the summary - Medium impact
Jubilant Ingrevia Q4 FY26 Earnings Call Transcript Released; Board Recommends Final Dividend of ₹2.5/Share
Jubilant Ingrevia released its Q4 FY26 earnings call transcript. The company reported its highest quarterly revenue and EBITDA in 14 quarters. The Board recommended a final dividend of ₹2.5 per share. Q4 revenue was ₹1,179 crore (up 12% YoY) and EBITDA ₹172 crore (up 11% YoY). The company anticipates sequential growth from Q1 FY27.
Read the summary - Low impact
Jubilant Ingrevia to Participate in Kotak Institutional Equity India Corporate Day in Singapore
Jubilant Ingrevia Limited will participate in the Kotak Institutional Equity, India Corporate Day 2026 in Singapore on June 9-10, 2026. Management will hold group and one-on-one meetings with investors and analysts.
Read the summary - Low impact
Jubilant Ingrevia to Participate in Kotak Institutional Equity India Corporate Day
Jubilant Ingrevia will attend the Kotak Institutional Equity India Corporate Day in Singapore on June 9-10, 2026. Management will hold group and one-on-one meetings with investors and analysts.
Read the summary - Low impact
Jubilant Ingrevia Publishes Audited Financial Results for Q4FY26
Jubilant Ingrevia Limited announced its audited standalone and consolidated financial results for the quarter and financial year ended March 31, 2026. The results were approved by the Board on May 26, 2026, and published on May 27, 2026.
Read the summary - Low impact
Jubilant Ingrevia Uploads Audio Recording of Q4FY26 Investor Conference Call
Jubilant Ingrevia Limited has made available the audio recording of its investor conference call held on May 26, 2026. The call discussed the audited financial results for the quarter and fiscal year ended March 31, 2026.
Read the summary - High impact
Jubilant Ingrevia Q4 FY26 Revenue Up 12% to ₹1,179 Cr, Recommends Final Dividend ₹2.50/Share
Jubilant Ingrevia's Q4 FY26 revenue grew 12% YoY to ₹1,179 crore, with EBITDA up 11% YoY to ₹172 crore. PAT rose 17% YoY to ₹86 crore. The company recommended a final dividend of ₹2.50 per share, totaling ₹5 per share for FY26. Key highlights include successful dispatch from the new Agro CDMO facility and the acquisition of Remidex Pharma.
Read the summary - High impact
Jubilant Ingrevia Q4 FY26: Revenue Up 12% to ₹1,179 Cr, EBITDA Rises 11% to ₹172 Cr
Jubilant Ingrevia reported Q4 FY26 revenue of ₹1,179 crore (up 12% YoY) and EBITDA of ₹172 crore (up 11% YoY). The company recommended a final dividend of ₹2.50 per share. Key highlights include the acquisition of Remidex Pharma and effective management of supply chain disruptions. FY27 outlook is positive, expecting growth led by Specialty Chemicals and Nutrition.
Read the summary - Medium impact
Jubilant Ingrevia Recommends 250% Final Dividend; Sets July 24 Record Date
Jubilant Ingrevia recommended a final dividend of 250% (₹2.50 per share) for FY26. The company set July 24, 2026, as the record date for dividend payment. M/s J.K. Kabra & Co. were re-appointed as Cost Auditors for FY27.
Read the summary - Medium impact
Jubilant Ingrevia Recommends Final Dividend of 250% (₹2.50/share), Sets July 24 as Record Date
Jubilant Ingrevia's board recommended a final dividend of 250% (₹2.50 per share) for FY26. The record date for dividend payment is set for July 24, 2026. The company also re-appointed M/s J.K. Kabra & Co. as Cost Auditors for FY27.
Read the summary - Medium impact
Jubilant Ingrevia Recommends 250% Final Dividend; Sets July 24 Record Date
Jubilant Ingrevia recommended a final dividend of 250% (₹2.50 per share) for FY26. The record date for dividend payment is set as July 24, 2026. The company also re-appointed M/s J.K. Kabra & Co. as Cost Auditors for FY27.
Read the summary - Medium impact
Jubilant Ingrevia Approves Audited FY26 Results, Recommends ₹2.5 Dividend
Jubilant Ingrevia's Board approved audited standalone and consolidated results for FY26. A final dividend of ₹2.5 per share is recommended, making the total ₹5 per share for FY26. The company reported an exceptional item of ₹1304 lakhs due to New Labour Codes and acquired Remidex Pharma for ₹1628 lakhs.
Read the summary - Low impact
Jubilant Ingrevia receives Income Tax assessment order for AY 2023-24, plans appeal
Jubilant Ingrevia received an Income Tax assessment order for AY 2023-24 on May 20, 2026. The order involves notional adjustments of ₹19.87 crore under Transfer Pricing Rules. The company plans to appeal the order and does not foresee significant financial impact.
Read the summary - Low impact
Jubilant Ingrevia faces ₹2.03 Cr GST demand with appeal planned
Jubilant Ingrevia Limited received an order confirming a GST demand of ₹1,01,84,776 and a penalty of ₹1,01,84,776 for FY 2017-18. The company plans to appeal the order before the GSTAT, stating no material financial or operational impact.
Read the summary - Medium impact
Jubilant Ingrevia schedules investor conference call for March 31, 2026 results on May 26, 2026
Jubilant Ingrevia Limited will host an investor conference call on May 26, 2026, after submitting its audited financial results for the quarter and year ended March 31, 2026. The call will discuss financial performance and include a Q&A session.
Read the summary - Low impact
Jubilant Ingrevia Limited Clarifies No Material Price-Sensitive Information
Jubilant Ingrevia Limited clarified to NSE that there is no material unpublished price-sensitive information. The company assured timely disclosure of all relevant information.
Read the summary - Low impact
Jubilant Ingrevia Grants 3,43,569 Stock Options Under ESOP Plan 2021
Jubilant Ingrevia Limited granted 3,43,569 stock options under its ESOP Plan 2021. This includes 2,40,497 Performance Linked Stock Options and 1,03,072 Tenure Linked ESOPs. The exercise price is Re. 1 per share. Vesting is subject to conditions post-FY30 Financial Closure, with a one-year exercise period.
Read the summary - Low impact
Jubilant Ingrevia Files SEBI Reg 74(5) Certificate for Q4 FY26
Jubilant Ingrevia Limited filed a SEBI Regulation 74(5) certificate for the quarter ended March 31, 2026. The certificate confirms dematerialization of securities and updates to the register of owners.
Read the summary - Low impact
Jubilant Ingrevia Shareholders Approve Re-appointment of Independent Director
Jubilant Ingrevia's shareholders approved the re-appointment of Mrs. Ameeta Chatterjee as an Independent Director for a second 5-year term. The postal ballot resolution passed with a significant majority, with 97.95% of votes polled in favour.
Read the summary - Medium impact
Jubilant Ingrevia Completes Acquisition of Remidex Pharma's 100% Stake
Jubilant Ingrevia Limited has completed the acquisition of 100% equity stake in Remidex Pharma Private Limited. The company had previously entered into a Share Purchase Agreement for this transaction. The acquisition was finalized on March 30, 2026.
Read the summary - Low impact
Jubilant Ingrevia Closes Trading Window from April 1, 2026, for Q4 FY26 Results
Jubilant Ingrevia Limited will close its trading window from April 1, 2026, until 48 hours after the announcement of Q4 FY26 audited financial results. The date for the board meeting to declare these results will be intimated shortly.
Read the summary
Model portfolios
Filings are the raw material. These are what SEBI-registered experts build from them.
- Stocks
Bharat Rising
Built around India's own shifts: capex, household savings, energy and consumption.
Moderate-Aggressive25 holdings3+ yearsView portfolio - Stocks
All-Terrain
One equity portfolio instead of three: large, mid and small cap in a single book.
Moderate-Aggressive34 holdings3+ yearsView portfolio - Stocks
Core Compounders
Companies that have already been through a downturn and came out still growing.
Moderate20 holdings3+ yearsView portfolio - Stocks
Udaan
Fast-growing, less-covered companies still early in their runway.
Aggressive29 holdings5+ yearsView portfolio